KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Invested Capital: 2021-2025

Historic Return on Invested Capital for Castle Biosciences (CSTL) over the last 2 years, with Sep 2025 value amounting to -0.05%.

  • Castle Biosciences' Return on Invested Capital fell 5.00% to -0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.05%, marking a year-over-year decrease of 5.00%. This contributed to the annual value of 0.02% for FY2024, which is N/A change from last year.
  • Latest data reveals that Castle Biosciences reported Return on Invested Capital of -0.05% as of Q3 2025, which was down 3.20% from -0.05% recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Return on Invested Capital registered a high of 0.02% during Q4 2024, and its lowest value of -0.25% during Q2 2023.
  • Moreover, its 3-year median value for Return on Invested Capital was -0.05% (2025), whereas its average is -0.08%.
  • In the last 5 years, Castle Biosciences' Return on Invested Capital declined by 14bps in 2023 and then increased by 22bps in 2024.
  • Castle Biosciences' Return on Invested Capital (Quarterly) stood at -0.08% in 2021, then dropped by 8bps to -0.15% in 2022, then dropped by 14bps to -0.25% in 2023, then rose by 22bps to 0.02% in 2024, then decreased by 5bps to -0.05% in 2025.
  • Its Return on Invested Capital stands at -0.05% for Q3 2025, versus -0.05% for Q2 2025 and 0.02% for Q4 2024.